Evidence map›Paper›PMID 41307733›Full record

ArticleJournal of molecular modeling2025

Modeling molecular environment of allomorphic N-salicylidene-4-halo-aniline crystals through iterative QM/QM' structural optimization.

Mingge Xu, Masahiro Suzuki, Ryo Koibuchi, Isao Yoshikawa, Hirohiko Houjou

Abstract read
In one paragraph

Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingge XuInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8505, Japan.
Masahiro SuzukiInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8505, Japan.
Ryo KoibuchiInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8505, Japan.
Isao YoshikawaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8505, Japan.
Hirohiko HoujouInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8505, Japan. houjou@iis.u-tokyo.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextTwo allomorphic crystals, photochromic N-salicylidene-4-bromoaniline (α-SA4B) and non-photochromic N-salicylidene-4-chloroaniline (β-SA4C), were simulated using a hierarchical hybrid quantum mechanical (QM/QM') method. Despite the similar potential energy surface (PES) profiles observed in their isolated forms, distinct differences emerged in the cluster model simulations of α-SA4B and β-SA4C. This observation suggests that the molecular environment influenced the torsional energy landscape associated with their chromic properties.

methodEach crystal was represented by a cluster model consisting of a central molecule and 14 peripheral molecules arranged based on crystallographic symmetry. The central molecule was treated as the high-level QM layer, while the surrounding molecules were kept fixed as the low-level QM' layer. Following iterative optimization of the cluster model, the PES was calculated to track the cis-trans isomerization process of the central molecule. The iterative optimization was conducted with ONIOM (B3LYP/6-311G**: HF-D3BJ/6-31G*), and the PES was calculated with the same level. For each cluster model, the excited state was calculated with the TD-DFT method. All the quantum chemical calculations were performed using Gaussian 16 software.

Indexed as

ChromismCrystal engineeringNormal-mode analysisPolymorphismSchiff base

Identifiers

PMID41307733
PMCPMC12660421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.